Back to Browse Journals » Cancer Management and Research » Volume 4

Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma

Authors Bonetta A, Di Pierro F

Received 25 June 2012

Accepted for publication 19 July 2012

Published 24 August 2012 Volume 2012:4 Pages 281—286


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Alberto Bonetta,1 Francesco Di Pierro2

1Unità Operativa Radioterapia Oncologica, Istituti Ospedalieri di Cremona, Cremona; 2Velleja Research, Milan, Italy

Background: Cranberry (Vaccinium macrocarpon) proanthocyanidins can interfere with adhesion of bacteria to uroepithelial cells, potentially preventing lower urinary tract infections (LUTIs). Because LUTIs are a common side effect of external beam radiotherapy (EBRT) for prostate cancer, we evaluated the clinical efficacy of enteric-coated tablets containing highly standardized V. msacrocarpon (ecVM) in this condition.
Methods: A total of 370 consecutive patients were entered into this study. All patients received intensity-modulated radiotherapy for prostate cancer; 184 patients were also treated with ecVM while 186 served as controls. Cranberry extract therapy started on the simulation day, at which time a bladder catheterization was performed. During EBRT (over 6–7 weeks), all patients underwent weekly examination for urinary tract symptoms, including regular urine cultures during the treatment period.
Results: Compliance was excellent, with no adverse effects or allergic reactions being observed, apart from gastric pain in two patients. In the cranberry cohort (n = 184), 16 LUTIs (8.7%) were observed, while in the control group (n = 186) 45 LUTIs (24.2%) were recorded. This difference was statistically significant. Furthermore, lower rates of nocturia, urgency, micturition frequency, and dysuria were observed in the group that received cranberry extract.
Conclusion: Cranberry extracts have been reported to reduce the incidence of LUTIs significantly in women and children. Our data extend these results to patients with prostate cancer undergoing irradiation to the pelvis, who had a significant reduction in LUTIs compared with controls. These results were accompanied by a statistically significant reduction in urinary tract symptoms (dysuria, nocturia, urinary frequency, urgency), suggesting a generally protective effect of cranberry extract on the bladder mucosa.

Keywords: urinary tract infection, cranberry, radiotherapy, prostate cancer

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other articles by this author:

Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children

Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS

Drug, Healthcare and Patient Safety 2014, 6:15-20

Published Date: 13 February 2014

Post-steroid management of chronic vulvar itching with a topical formula containing natural anti-itching and anti-inflammatory actives

Di Pierro F, Di Maio E, Di Paola G, Felice R, Murina F

International Journal of Women's Health 2013, 5:187-191

Published Date: 19 April 2013

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:213-217

Published Date: 17 July 2012

Readers of this article also read:

Gastroparesis: a review of current and emerging treatment options

Enweluzo C, Aziz F

Clinical and Experimental Gastroenterology 2013, 6:161-165

Published Date: 5 September 2013

The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period

Malaty HM, Mehta S, Abraham B, Garnett EA, Ferry GD

Clinical and Experimental Gastroenterology 2013, 6:115-121

Published Date: 23 July 2013

Oral bismuth for chronic intractable diarrheal conditions?

Thazhath SS, Haque M, Florin TH

Clinical and Experimental Gastroenterology 2013, 6:19-25

Published Date: 13 March 2013


Kukulka M, Eisenberg C, Nudurupati S

Clinical and Experimental Gastroenterology 2011, 4:255-256

Published Date: 14 October 2011